101 related articles for article (PubMed ID: 28901305)
1. Transarterial embolization with N-butyl 2-cyanoacrylate for the treatment of arterioportal shunts in patients with hepatocellular carcinoma.
Duan F; Bai Y; Cui L; Li X; Yan J; Zhu H
J Cancer Res Ther; 2017; 13(4):631-635. PubMed ID: 28901305
[TBL] [Abstract][Full Text] [Related]
2. Double-Balloon-Assisted n-Butyl-2-Cyanoacrylate Embolization of Intrahepatic Arterioportal Shunt Prior to Chemoembolization of Hepatocellular Carcinoma.
Takao H; Shibata E; Ohtomo K
Cardiovasc Intervent Radiol; 2016 Oct; 39(10):1479-83. PubMed ID: 27224984
[TBL] [Abstract][Full Text] [Related]
3. Polyvinyl alcohol embolization adjuvant to oily chemoembolization in advanced hepatocellular carcinoma with arterioportal shunts.
Kim YJ; Lee HG; Park JM; Lim YS; Chung MH; Sung MS; Yoo WJ; Lim HW
Korean J Radiol; 2007; 8(4):311-9. PubMed ID: 17673842
[TBL] [Abstract][Full Text] [Related]
4. Diaphragmatic weakness after transcatheter arterial chemoembolization of the right inferior phrenic artery for treatment of hepatocellular carcinoma: a comparison of outcomes after N-butyl cyanoacrylate versus gelatin sponge embolization.
Noh SY; Gwon DI; Park S; Yang WJ; Chu HH; Kim JW
Acta Radiol; 2022 Jan; 63(1):48-58. PubMed ID: 33356351
[TBL] [Abstract][Full Text] [Related]
5. Arterioportal shunts in patients with hepatocellular carcinoma treated using ethanol-soaked gelatin sponge: therapeutic effects and prognostic factors.
Zhou WZ; Shi HB; Liu S; Yang ZQ; Zhou CG; Xia JG; Zhao LB; Li LS
J Vasc Interv Radiol; 2015 Feb; 26(2):223-30. PubMed ID: 25645411
[TBL] [Abstract][Full Text] [Related]
6. Oxaliplatin and 5-fluorouracil hepatic infusion with lipiodolized chemoembolization in large hepatocellular carcinoma.
Li JH; Xie XY; Zhang L; Le F; Ge NL; Li LX; Gan YH; Chen Y; Zhang JB; Xue TC; Chen RX; Xia JL; Zhang BH; Ye SL; Wang YH; Ren ZG
World J Gastroenterol; 2015 Apr; 21(13):3970-7. PubMed ID: 25852283
[TBL] [Abstract][Full Text] [Related]
7. Transarterial embolization with cyanoacrylate for severe arterioportal shunt complicated by hepatocellular carcinoma.
Shi HB; Yang ZQ; Liu S; Zhou WZ; Zhou CG; Zhao LB; Xia JG; Li LS
Cardiovasc Intervent Radiol; 2013 Apr; 36(2):412-21. PubMed ID: 22580682
[TBL] [Abstract][Full Text] [Related]
8. Supplemental conventional transarterial embolization/chemoembolization therapy via extrahepatic arteries for hepatocellular carcinoma.
Huang Y; Jia Z; Tu J; Shen T; Tian F; Jiang G
J Cancer Res Ther; 2017; 13(4):720-724. PubMed ID: 28901321
[TBL] [Abstract][Full Text] [Related]
9. Addition of n-butyl cyanoacrylate to classic transarterial chemoembolization may improve the radiological response in patients with hepatocellular carcinoma.
Monsignore LM; Elias-Junior J; Muglia VF; Teixeira AC; Mente ED; Martinelli Ade L; Abud DG
Clinics (Sao Paulo); 2015 Dec; 70(12):781-9. PubMed ID: 26735217
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin-eluting beads versus conventional transarterial chemoembolization for the treatment of hepatocellular carcinoma.
Huang K; Zhou Q; Wang R; Cheng D; Ma Y
J Gastroenterol Hepatol; 2014 May; 29(5):920-5. PubMed ID: 24224722
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma: CT for tumor response after transarterial chemoembolization in patients exceeding Milan criteria--selection parameter for liver transplantation.
Bargellini I; Vignali C; Cioni R; Petruzzi P; Cicorelli A; Campani D; De Simone P; Filipponi F; Bartolozzi C
Radiology; 2010 Apr; 255(1):289-300. PubMed ID: 20308465
[TBL] [Abstract][Full Text] [Related]
12. Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study.
Lee S; Kim KM; Lee SJ; Lee KH; Lee DY; Kim MD; Kim DY; Kim SU; Won JY
Acta Radiol; 2017 Feb; 58(2):131-139. PubMed ID: 27217418
[TBL] [Abstract][Full Text] [Related]
13. Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma.
Kloeckner R; Weinmann A; Prinz F; Pinto dos Santos D; Ruckes C; Dueber C; Pitton MB
BMC Cancer; 2015 Jun; 15():465. PubMed ID: 26059447
[TBL] [Abstract][Full Text] [Related]
14. Conventional transarterial chemoembolization vs microsphere embolization in hepatocellular carcinoma: a meta-analysis.
Ni JY; Xu LF; Wang WD; Sun HL; Chen YT
World J Gastroenterol; 2014 Dec; 20(45):17206-17. PubMed ID: 25493037
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of sorafenib in intermediate-stage hepatocellular carcinoma patients refractory to transarterial chemoembolization.
Ogasawara S; Chiba T; Ooka Y; Kanogawa N; Motoyama T; Suzuki E; Tawada A; Kanai F; Yoshikawa M; Yokosuka O
Oncology; 2014; 87(6):330-41. PubMed ID: 25227534
[TBL] [Abstract][Full Text] [Related]
16. Transarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survival.
Chung GE; Lee JH; Kim HY; Hwang SY; Kim JS; Chung JW; Yoon JH; Lee HS; Kim YJ
Radiology; 2011 Feb; 258(2):627-34. PubMed ID: 21273524
[TBL] [Abstract][Full Text] [Related]
17. Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival.
Kirchhoff TD; Bleck JS; Dettmer A; Chavan A; Rosenthal H; Merkesdal S; Frericks B; Zender L; Malek NP; Greten TF; Kubicka S; Manns MP; Galanski M
Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):259-66. PubMed ID: 17548248
[TBL] [Abstract][Full Text] [Related]
18. Novel treatment strategy for advanced hepatocellular carcinoma: combination of conventional transcatheter arterial chemoembolization and modified method with portal vein occlusion for cases with arterioportal shunt: a preliminary study.
Yasui D; Murata S; Ueda T; Sugihara F; Onozawa S; Kawamoto C; Kumita S
Acta Radiol; 2018 Mar; 59(3):266-274. PubMed ID: 28651444
[TBL] [Abstract][Full Text] [Related]
19. Is Salvage Liver Resection Necessary for Initially Unresectable Hepatocellular Carcinoma Patients Downstaged by Transarterial Chemoembolization? Ten Years of Experience.
Zhang Y; Huang G; Wang Y; Liang L; Peng B; Fan W; Yang J; Huang Y; Yao W; Li J
Oncologist; 2016 Dec; 21(12):1442-1449. PubMed ID: 27486202
[TBL] [Abstract][Full Text] [Related]
20. Sorafenib in combination with transarterial chemoembolization and bronchial arterial chemoinfusion in the treatment of hepatocellular carcinoma with pulmonary metastasis.
Duan F; Wang MQ; Liu FY; Wang ZJ; Song P; Wang Y
Asia Pac J Clin Oncol; 2012 Jun; 8(2):156-63. PubMed ID: 22524574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
